Time: 2024-09-19
In a surprise bend of event , all seven mugwump director of 23andMe vacate from the company 's board following a dispute over CEO Anne Wojcicki 's plan to return the familial - testing company private . The move , effective immediately , Marks a major reorganization for the embattle company know for its deoxyribonucleic_acid testing kit . The stock monetary_value plummet to sh.30 after the mass resignation , highlight the ongoing struggle of the company since departure populace in 2021 . Despite Wojcicki 's control of 49 % of the company 's vote , the resignation bespeak a significant disagreement over the strategic direction of 23andMe.
In response to the board 's resignation , CEO Anne Wojcicki express surprise and disappointment , but remains firm in her committedness to pickings 23andMe private . She belief that denationalization is the best way forward for the company 's hanker - term success . Wojcicki is now concentrate on determination new mugwump director who support this vision and will supply update on the situation in the approach days . Despite the Holocene challenge confront by the company , include worsen deoxyribonucleic_acid trial gross_sales and a data breach affect million of customer , Wojcicki remains optimistic about the future of 23andMe 's drug development and familial sequence efforts.
following the resignation of the board of director , 23andMe 's market cap has drop significantly to under 00 million , a Army_for_the_Liberation_of_Rwanda cry from its previous evaluation of .5 billion . The share monetary_value close at 34 cent after the announcement , reflect the ongoing convulsion surround the company . Despite these challenge , Wojcicki is confident that the company 's focus on personalize health and health offer will ultimately lead to success . The road ahead may be disruptive , but Wojcicki is determine to tip 23andMe in the right direction.
establish in 2006 by Anne Wojcicki , 23andMe has been a pioneer in familial testing and healthcare invention . The Holocene development see the board of director highlight the internal struggle and disagreement over the company 's direction . As Wojcicki voyage this challenge time_period , the future of 23andMe remains uncertain but full_moon of potential . The decision to return the company private represent a boldface move that could reshape its trajectory in the old_age to semen . Despite the reverse , Wojcicki 's firm dedication to the company 's mission underscore her committedness to drive change in the healthcare industry.
Business
